BioMed Realty Trust, Inc. (BMR) Reports In-Line Q2 FFO, Revenues Top Slightly
Tweet
Share
E-mailGet Alerts BMR Hot Sheet
Price: $1.29 -2.27%
Financial Fact:
Equity in net loss of unconsolidated partnerships: 242K
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Equity in net loss of unconsolidated partnerships: 242K
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
BioMed Realty Trust, Inc. (NYSE: BMR) reported Q2 FFO of $0.29, in-line with the analyst estimate of $0.29. Revenue for the quarter came in at $106.8 million versus the consensus estimate of $105.56 million.
BioMed Realty Trust, Inc. sees FY2011 FFO of $1.16-$1.20, versus the consensus of $1.18.
BioMed Realty Trust, Inc. sees FY2011 FFO of $1.16-$1.20, versus the consensus of $1.18.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22
- InspireMD (NSPR) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
